Scarica l'app Stockscreener
279.25
0.63%
1.75
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$277.50
Aprire:
$278.25
Volume 24 ore:
276.58K
Relative Volume:
0.95
Capitalizzazione di mercato:
$7.54B
Reddito:
$2.58B
Utile/perdita netta:
$759.90M
Rapporto P/E:
10.00
EPS:
27.9168
Flusso di cassa netto:
$374.60M
1 W Prestazione:
-0.26%
1M Prestazione:
+4.26%
6M Prestazione:
-6.20%
1 anno Prestazione:
+20.22%
Intervallo 1D:
$275.40
$279.52
Intervallo di 1 settimana:
$270.37
$288.72
Portata 52W:
$211.43
$343.12
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Nome
Bio Rad Laboratories Inc
Settore
Industria
Telefono
(510) 724-7000
Indirizzo
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
279.25 | 7.49B | 2.58B | 759.90M | 374.60M | 27.92 |
ABT
Abbott Laboratories
|
100.30 | 178.49B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
339.15 | 129.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.21 | 112.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.79 | 91.07B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
77.87 | 45.63B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-04-03 | Downgrade | Citigroup | Buy → Neutral |
| 2023-12-07 | Iniziato | UBS | Buy |
| 2023-06-16 | Iniziato | Wells Fargo | Overweight |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-01-28 | Reiterato | Citigroup | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2018-10-17 | Iniziato | Goldman | Buy |
| 2018-09-20 | Iniziato | Morgan Stanley | Equal-Weight |
| 2018-02-16 | Downgrade | CL King | Buy → Neutral |
| 2017-07-13 | Iniziato | Wells Fargo | Outperform |
| 2017-06-28 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2017-01-18 | Iniziato | Deutsche Bank | Hold |
| 2016-10-13 | Iniziato | CL King | Buy |
| 2015-05-06 | Reiterato | Jefferies | Buy |
| 2009-12-18 | Iniziato | Maxim Group | Buy |
| 2009-11-06 | Iniziato | Jefferies & Co | Buy |
| 2009-07-17 | Iniziato | Soleil | Buy |
| 2007-09-26 | Iniziato | Banc of America Sec | Buy |
| 2007-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mostra tutto
Bio Rad Laboratories Inc Borsa (BIO) Ultime notizie
Breakout Move: What is the long term forecast for Bio Rad Laboratories Inc stockProduct Launch & Real-Time Volume Analysis - baoquankhu1.vn
Life Science Instrumentation Market (2026-2033) | Proteomics, - openPR.com
Market Outlook: Is Bio Rad Laboratories Inc likely to announce a buybackSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Bio-Rad Laboratories, Inc. (BIO) Stock Forecasts - Yahoo Finance
Understanding Momentum Shifts in (BIO) - Stock Traders Daily
Aug Momentum: Whats the fair value of Bio Rad Laboratories Inc stockMarket Activity Report & Community Trade Idea Sharing Platform - baoquankhu1.vn
Bio-Rad Laboratories Cut to Neutral From Buy by Citigroup - Moomoo
Bio-Rad Laboratories (BIO) Downgraded by Citigroup with Lower Pr - GuruFocus
Is Bio Rad Laboratories Inc likely to announce a buybackStock Surge & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Citigroup downgrades Bio-Rad Laboratories (BIO) - MSN
DNA/RNA Extraction Kit Market to Reach US$6.78 Billion by 2033 - openPR.com
Protein Chip Market to Reach US$4.8 Billion by 2033 at 7.5% CAGR; - openPR.com
BIO Technical Analysis & Stock Price Forecast - Intellectia AI
BIO Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Bio-Rad Laboratories, Inc. (BIO) Stock forecasts - Yahoo Finance UK
Single-cell Omics Market Is Going to Boom Rapidly |Bio-Rad - openPR.com
Shigella Test Kit Market Set to Boom Rapidly, Witnessing Strong - openPR.com
Allspring Global Investments Reduces Stake in Bio-Rad Laboratories - National Today
Outlook on the PCR and Realtime PCR Testing Market: Major - openPR.com
Allspring Global Investments Holdings LLC Decreases Stake in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Drug Screening Market Trends 2026–2031: Chromatography and Mass Spectrometry Held a 44.77% Share in 2025 Amid Growing Demand for Advanced Testing, Reports Mordor Intelligence - GlobeNewswire Inc.
BIO.B Should I Buy - intellectia.ai
Bio-Rad Laboratories Stock: Life Sciences Leader Faces Earnings Challenges Amid Strong Balance Sheet - AD HOC NEWS
Artisan Mid Cap Value Fund Sold Bio-Rad Laboratories (BIO) in Q4 - Insider Monkey
Molecular Quality Controls Market Set to Surge as Precision - openPR.com
SG Americas Securities LLC Buys 12,544 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories (NYSE:BIO.B) Stock Price Up 3.6%Time to Buy? - MarketBeat
BIO SEC FilingsBio Rad Labs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Bio-Rad Laboratories Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
US Polymerase Chain Reaction Market Set to Boom Rapidly, - openPR.com
Wellness and Longevity Diagnostics Market Hits New High | Major - openPR.com
U.S. Magnetic Beads Market is Booming with Strong Growth - openPR.com
Calorimetric Biosensor Market Is Going to Boom | PerkinElmer Inc. • Bio-Rad Laboratories Inc - openPR.com
Malaria Diagnostics Market Projected To Witness Massive - openPR.com
Real Time PCR and Digital PCR Market Set to Boom Rapidly by 2033| - openpr.com
Exchange Traded Concepts LLC Has $8.97 Million Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Bio-Rad Laboratories Stock: A Cornerstone in Life Sciences Tools Amid Precision Medicine Momentum - AD HOC NEWS
Is Bio Rad Laboratories Inc a cyclical or defensive stockWeekly Trade Review & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Stock List: Research Stocks from Around the World - gurufocus.com
Electrophoresis Reagents Market Expands with North America - openPR.com
Vanguard disaggregates holdings; Bio‑Rad Labs (NYSE: BIO) shows 0 shares - Stock Titan
Bio-Rad Laboratories Forms Death Cross, Signaling Bearish Trend Ahead - Markets Mojo
Executive pay, equity plan and dual-class vote at Bio-Rad (NYSE: BIO) 2026 meeting - Stock Titan
[ARS] BIO-RAD LABORATORIES, INC. SEC Filing - Stock Titan
Biosensors Market Is Going to BoomKey Factors Driving - openPR.com
Enzyme Linked Immunosorbent Assay Market Future Business - openPR.com
BIO Technical Analysis | Trend, Signals & Chart Patterns | BIO-RAD LABORATORIES-A (NYSE:BIO) - ChartMill
Retail Trends: What is the long term forecast for Bio Rad Laboratories Inc. stock2026 Breakouts & Free Safe Entry Trade Signal Reports - baoquankhu1.vn
Bio-Rad Laboratories Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends - Markets Mojo
Disappointing Results Hurt Bio-Rad Laboratories (BIO) - Insider Monkey
Moving Averages: Is Bio Rad Laboratories Inc likely to announce a buybackWeekly Trend Summary & Breakout Confirmation Alerts - baoquankhu1.vn
Bio Rad Laboratories Inc Azioni (BIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.10%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):